Abstract
BackgroundAndrogen deprivation therapy (ADT) is the mainstay of treatment for non-metastatic prostate cancer1. It is known to have adverse effects including fatigue, anaemia, a decrease in lean body mass as...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
